Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer

Download All
In this online program with content from a live symposium, experts discuss recent advances in the management of HR-positive/HER2-negative breast cancer. Watch the on-demand webcast from the live event, download the symposium slides, and read expert commentary on current clinical questions in this setting.
Allison Butts, PharmD, BCOP
Kristina F. Byers, PharmD, BCOP


In this commentary, we discuss updates on the use of oral targeted therapies for the treatment of HR-positive/HER2-negative early and metastatic breast cancer, adverse event management, and tools for adherence.

Allison Butts, PharmD, BCOP Kristina F. Byers, PharmD, BCOP Released: April 25, 2022
Provided by ProCE, LLC in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings